Plakophilins 1 and 3 Bind to FXR1 and thereby influence the mRNA stability of desmosomal proteins

Molecular and Cellular Biology

Volumn 34, Issue 23, 2014, Pages 4244-4256

  Fischer Kešo, Regina ^a,b   Breuninger, Sonja ^a,b,e   Hofmann, Sarah ^a,c   Henn, Manuela ^b   Röhrig, Theresa ^a   Ströbel, Philipp ^d   Stoecklin, Georg ^a,c   Hofmann, Ilse ^a,b  

^a GERMAN CANCER RESEARCH CENTER   (Germany)

^b MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e WITec Wissenschaftliche Instrumente und Technologie GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATENIN; DESMOPLAKIN; FXR1 PROTEIN; G3BP PROTEIN; MESSENGER RNA; PABPC1 PROTEIN; PLAKOPHILIN; PLAKOPHILIN 1; PLAKOPHILIN 3; RIBONUCLEASE; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; UPF1 PROTEIN; CARRIER PROTEIN; FXR1 PROTEIN, HUMAN; G3BP PROTEIN, HUMAN; PABPC1L PROTEIN, HUMAN; PKP1 PROTEIN, HUMAN; PKP3 PROTEIN, HUMAN; POLYADENYLIC ACID BINDING PROTEIN; PROTEIN BINDING; TRANSACTIVATOR PROTEIN; UPF1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; DESMOSOME; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; LOSS OF FUNCTION MUTATION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STABILITY; CELL ADHESION; CELL LINE; GENE SILENCING; GENETICS; HUMAN; METABOLISM; RNA STABILITY;

CARRIER PROTEINS; CELL ADHESION; CELL LINE; DESMOPLAKINS; DESMOSOMES; GENE KNOCKDOWN TECHNIQUES; HUMANS; PLAKOPHILINS; POLY(A)-BINDING PROTEINS; PROTEIN BINDING; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS; TRANS-ACTIVATORS;

EID: 84909582227     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00766-14     Document Type: Article

References (90)

1. Valenta T, Hausmann G, Basler K. 2012. The many faces and functions of beta-catenin. EMBOJ. 31:2714-2736. http://dx.doi.org/10.1038/emboj .2012.150.
2. Carnahan RH, Rokas A, Gaucher EA, Reynolds AB. 2010. The molecular evolution of the p120-catenin subfamily and its functional associations. PLoS One 5:e15747. http://dx.doi.org/10.1371/journal.pone.0015747.
3. Neuber S, Muhmer M, Wratten D, Koch PJ, Moll R, Schmidt A. 2010. The desmosomal plaque proteins of the plakophilin family. Dermatol. Res. Pract. 2010:101452. http://dx.doi.org/10.1155/2010/101452.
4. Bonne S, Gilbert B, Hatzfeld M, Chen X, Green KJ, van Roy F. 2003. Defining desmosomal plakophilin-3 interactions. J. Cell Biol. 161:403- 416. http://dx.doi.org/10.1083/jcb.200303036.
5. Holthofer B, Windoffer R, Troyanovsky S, Leube RE. 2007. Structure and function of desmosomes. Int. Rev. Cytol. 264:65-163. http://dx.doi .org/10.1016/S0074-7696(07)64003-0.
6. Hatzfeld M. 2007. Plakophilins: multifunctional proteins or just regulators of desmosomal adhesion? Biochim. Biophys. Acta 1773:69-77. http: //dx.doi.org/10.1016/j.bbamcr.2006.04.009.
7. McMillan JR, Haftek M, Akiyama M, South AP, Perrot H, McGrath JA, Eady RA, Shimizu H. 2003. Alterations in desmosome size and number coincide with the loss of keratinocyte cohesion in skin with homozygous and heterozygous defects in the desmosomal protein plakophilin 1. J. Invest. Dermatol. 121:96-103. http://dx.doi.org/10.1046/j.1523-1747.2003 .12324.x.
8. South AP, Wan H, Stone MG, Dopping-Hepenstal PJ, Purkis PE, Marshall JF, Leigh IM, Eady RA, Hart IR, McGrath JA. 2003. Lack of plakophilin 1 increases keratinocyte migration and reduces desmosome stability. J. Cell Sci. 116:3303-3314. http://dx.doi.org/10.1242/jcs.00636.
9. Kundu ST, Gosavi P, Khapare N, Patel R, Hosing AS, Maru GB, Ingle A, Decaprio JA, Dalal SN. 2008. Plakophilin3 downregulation leads to a decrease in cell adhesion and promotes metastasis. Int. J. Cancer 123: 2303-2314. http://dx.doi.org/10.1002/ijc.23797.
10. Pieters T, van Roy F, van Hengel J. 2012. Functions of p120ctn isoforms in cell-cell adhesion and intracellular signaling. Front. Biosci. 17:1669- 1694. http://dx.doi.org/10.2741/4012.
11. Bass-Zubek AE, Hobbs RP, Amargo EV, Garcia NJ, Hsieh SN, Chen X, Wahl JK, III, Denning MF, Green KJ. 2008. Plakophilin 2: a critical scaffold for PKC alpha that regulates intercellular junction assembly. J. Cell Biol. 181:605-613. http://dx.doi.org/10.1083/jcb.200712133.
12. Mariner DJ, Wang J, Reynolds AB. 2000. ARVCF localizes to the nucleus and adherens junction and is mutually exclusive with p120(ctn) in Ecadherin complexes. J. Cell Sci. 113:1481-1490.
13. Bass-Zubek AE, Godsel LM, Delmar M, Green KJ. 2009. Plakophilins: multifunctional scaffolds for adhesion and signaling. Curr. Opin. Cell Biol. 21:708-716. http://dx.doi.org/10.1016/j.ceb.2009.07.002.
14. Cho K, Vaught TG, Ji H, Gu D, Papasakelariou-Yared C, Horstmann N, Jennings JM, Lee M, Sevilla LM, Kloc M, Reynolds AB, Watt FM, Brennan RG, Kowalczyk AP, McCrea PD. 2010. Xenopus kazrin interacts with ARVCF-catenin, spectrin and p190B RhoGAP, and modulates RhoA activity and epithelial integrity. J. Cell Sci. 123:4128-4144. http://dx .doi.org/10.1242/jcs.072041.
15. McCrea PD, Gu D. 2010. The catenin family at a glance. J. Cell Sci. 123:637-642. http://dx.doi.org/10.1242/jcs.039842.
16. Schmidt A, Langbein L, Rode M, Pratzel S, Zimbelmann R, Franke WW. 1997. Plakophilins 1a and 1b: widespread nuclear proteins recruited in specific epithelial cells as desmosomal plaque components. Cell Tissue Res. 290:481-499. http://dx.doi.org/10.1007/s004410050956.
17. Wolf A, Krause-Gruszczynska M, Birkenmeier O, Ostareck-Lederer A, Huttelmaier S, Hatzfeld M. 2010. Plakophilin 1 stimulates translation by promoting eIF4A1 activity. J. Cell Biol. 188:463-471. http://dx.doi.org/10 .1083/jcb.200908135.
18. Mertens C, Hofmann I, Wang Z, Teichmann M, Sepehri Chong S, Schnolzer M, Franke WW. 2001. Nuclear particles containing RNA polymerase III complexes associated with the junctional plaque protein plakophilin 2. Proc. Natl. Acad. Sci. U. S. A. 98:7795-7800. http://dx.doi.org/10 .1073/pnas.141219498.
19. Mertens C, Kuhn C, Franke WW. 1996. Plakophilins 2a and 2b: constitutive proteins of dual location in the karyoplasm and the desmosomal plaque. J. Cell Biol. 135:1009-1025. http://dx.doi.org/10.1083/jcb.135.4 .1009.
20. Hofmann I, Casella M, Schnolzer M, Schlechter T, Spring H, Franke WW.2006. Identification of the junctional plaque protein plakophilin 3 in cytoplasmic particles containing RNA-binding proteins and the recruitment of plakophilins 1 and 3 to stress granules. Mol. Biol. Cell 17:1388- 1398. http://dx.doi.org/10.1091/mbc.E05-08-0708.
21. Yang C, Strobel P, Marx A, Hofmann I. 2013. Plakophilin-associated RNA-binding proteins in prostate cancer and their implications in tumor progression and metastasis. Virchows Arch. 463:379-390. http://dx.doi .org/10.1007/s00428-013-1452-y.
22. Kedersha N, Anderson P. 2007. Mammalian stress granules and processing bodies. Methods Enzymol. 431:61-81. http://dx.doi.org/10.1016 /S0076-6879(07)31005-7.
23. Vasudevan S, Steitz JA. 2007. AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell 128:1105-1118. http://dx .doi.org/10.1016/j.cell.2007.01.038.
24. Garnon J, Lachance C, Di Marco S, Hel Z, Marion D, Ruiz MC, Newkirk MM, Khandjian EW, Radzioch D. 2005. Fragile X-related protein FXR1P regulates proinflammatory cytokine tumor necrosis factor expression at the post-transcriptional level. J. Biol. Chem. 280:5750-5763. http://dx.doi.org/10.1074/jbc.M401988200.
25. Lachance C, Thuraisingam T, Garnon J, Roter E, Radzioch D. 2007. Posttranscriptional gene expression regulation in CpG-activated macrophages depends on FXR1P RNA-binding protein. FEMS Immunol. Med. Microbiol. 51:422- 430. http://dx.doi.org/10.1111/j.1574-695X .2007.00317.x.
26. Khera TK, Dick AD, Nicholson LB. 2010. Fragile X-related protein FXR1 controls post-transcriptional suppression of lipopolysaccharide-induced tumour necrosis factor-alpha production by transforming growth factorbeta1. FEBS J. 277:2754-2765. http://dx.doi.org/10.1111/j.1742-4658 .2010.07692.x.
27. Irvine K, Stirling R, Hume D, Kennedy D. 2004. Rasputin, more promiscuous than ever: a review of G3BP. Int. J. Dev. Biol. 48:1065-1077. http://dx.doi.org/10.1387/ijdb.041893ki.
28. Li WM, Barnes T, Lee CH. 2010. Endoribonucleases-enzymes gaining spotlight in mRNA metabolism. FEBS J. 277:627-641. http://dx.doi.org /10.1111/j.1742-4658.2009.07488.x.
29. Ortega AD, Willers IM, Sala S, Cuezva JM. 2010. Human G3BP1 interacts with beta-F1-ATPase mRNA and inhibits its translation. J. Cell Sci. 123:2685-2696. http://dx.doi.org/10.1242/jcs.065920.
30. Mangus DA, Evans MC, Jacobson A. 2003. Poly(A)-binding proteins: multifunctional scaffolds for the post-transcriptional control of gene expression. Genome Biol. 4:223. http://dx.doi.org/10.1186/gb-2003-4-7 -223.
31. Amrani N, Ghosh S, Mangus DA, Jacobson A. 2008. Translation factors promote the formation of two states of the closed-loop mRNP. Nature 453:1276-1280. http://dx.doi.org/10.1038/nature06974.
32. Preiss T, Hentze MW. 2003. Starting the protein synthesis machine: eukaryotic translation initiation. Bioessays 25:1201-1211. http://dx.doi .org/10.1002/bies.10362.
33. Martineau Y, Derry MC, Wang X, Yanagiya A, Berlanga JJ, Shyu AB, Imataka H, Gehring K, Sonenberg N. 2008. Poly(A)-binding proteininteracting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate translation. Mol. Cell. Biol. 28:6658-6667. http://dx.doi.org/10 .1128/MCB.00738-08.
34. Gray NK, Coller JM, Dickson KS, Wickens M. 2000. Multiple portions of poly(A)-binding protein stimulate translation in vivo. EMBO J. 19: 4723-4733. http://dx.doi.org/10.1093/emboj/19.17.4723.
35. Tritschler F, Huntzinger E, Izaurralde E. 2010. Role of GW182 proteins and PABPC1 in the miRNA pathway: a sense of deja vu. Nat. Rev. Mol. Cell Biol. 11:379-384. http://dx.doi.org/10.1038/nrm2885.
36. Fabian MR, Mathonnet G, Sundermeier T, Mathys H, Zipprich JT, Svitkin YV, Rivas F, Jinek M, Wohlschlegel J, Doudna JA, Chen CY, Shyu AB, Yates JR, III, Hannon GJ, Filipowicz W, Duchaine TF, Sonenberg N. 2009. Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. Mol. Cell 35:868-880. http://dx .doi.org/10.1016/j.molcel.2009.08.004.
37. Zekri L, Huntzinger E, Heimstadt S, Izaurralde E. 2009. The silencing domain of GW182 interacts with PABPC1 to promote translational repression and degradation of microRNA targets and is required for target release. Mol. Cell. Biol. 29:6220-6231. http://dx.doi.org/10.1128/MCB .01081-09.
38. Huntzinger E, Braun JE, Heimstadt S, Zekri L, Izaurralde E. 2010. Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. EMBO J. 29:4146-4160. http://dx.doi.org/10.1038/emboj .2010.274.
39. Cosson B, Berkova N, Couturier A, Chabelskaya S, Philippe M, Zhouravleva G. 2002. Poly(A)-binding protein and eRF3 are associated in vivo in human and Xenopus cells. Biol. Cell 94:205-216. http://dx.doi.org /10.1016/S0248-4900(02)01194-2.
40. Ivanov PV, Gehring NH, Kunz JB, Hentze MW, Kulozik AE. 2008. Interactions between UPF1, eRFs, PABP and the exon junction complex suggest an integrated model for mammalian NMD pathways. EMBO J. 27:736-747. http://dx.doi.org/10.1038/emboj.2008.17.
41. Hogg JR, Goff SP. 2010. Upf1 senses 3'UTR length to potentiate mRNA decay. Cell 143:379-389. http://dx.doi.org/10.1016/j.cell.2010.10.005.
42. Nicholson P, Yepiskoposyan H, Metze S, Zamudio Orozco R, Kleinschmidt N, Muhlemann O. 2010. Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell. Mol. Life Sci. 67:677-700. http://dx .doi.org/10.1007/s00018-009-0177-1.
43. Kervestin S, Jacobson A. 2012. NMD: a multifaceted response to premature translational termination. Nat. Rev. Mol. Cell Biol. 13:700-712. http: //dx.doi.org/10.1038/nrm3454.
44. Czaplinski K, Weng Y, Hagan KW, Peltz SW. 1995. Purification and characterization of the Upf1 protein: a factor involved in translation and mRNA degradation. RNA 1:610-623.
45. Stalder L, Muhlemann O. 2008. The meaning of nonsense. Trends Cell Biol. 18:315-321. http://dx.doi.org/10.1016/j.tcb.2008.04.005.
46. Collins LJ, Kurland CG, Biggs P, Penny D. 2009. The modern RNP world of eukaryotes. J. Hered. 100:597-604. http://dx.doi.org/10.1093 /jhered/esp064.
47. Glisovic T, Bachorik JL, Yong J, Dreyfuss G. 2008. RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett. 582:1977-1986. http://dx.doi.org/10.1016/j.febslet.2008.03.004.
48. Keene JD, Tenenbaum SA. 2002. Eukaryotic mRNPs may represent posttranscriptional operons. Mol. Cell 9:1161-1167. http://dx.doi.org/10 .1016/S1097-2765(02)00559-2.
49. Breuninger S, Reidenbach S, Sauer CG, Strobel P, Pfitzenmaier J, Trojan L, Hofmann I. 2010. Desmosomal plakophilins in the prostate and prostatic adenocarcinomas: implications for diagnosis and tumor progression. Am. J. Pathol. 176:2509-2519. http://dx.doi.org/10.2353 /ajpath.2010.090737.
50. Jin H, Suh MR, Han J, Yeom KH, Lee Y, Heo I, Ha M, Hyun S, Kim VN. 2009. Human UPF1 participates in small RNA-induced mRNA downregulation. Mol. Cell. Biol. 29:5789-5799. http://dx.doi.org/10.1128 /MCB.00653-09.
51. Scott SD, Joiner MC, Marples B. 2002. Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy. Gene Ther. 9:1396-1402. http://dx.doi.org/10.1038/sj.gt.3301822.
52. Huang L, Lou CH, Chan W, Shum EY, Shao A, Stone E, Karam R, Song HW, Wilkinson MF. 2011. RNA homeostasis governed by cell typespecific and branched feedback loops acting on NMD. Mol. Cell 43:950- 961. http://dx.doi.org/10.1016/j.molcel.2011.06.031.
53. Hwang J, Sato H, Tang Y, Matsuda D, Maquat LE. 2010. UPF1 association with the cap-binding protein, CBP80, promotes nonsense-mediated mRNA decay at two distinct steps. Mol. Cell 39:396-409. http://dx.doi .org/10.1016/j.molcel.2010.07.004.
54. Kim YK, Furic L, Desgroseillers L, Maquat LE. 2005. Mammalian Staufen1 recruits Upf1 to specific mRNA 3'UTRs so as to elicit mRNA decay. Cell 120:195-208. http://dx.doi.org/10.1016/j.cell.2004.11.050.
55. Whitman SA, Cover C, Yu L, Nelson DL, Zarnescu DC, Gregorio CC. Desmoplakin and talin2 are novel mRNA targets of fragile x-related protein-1 in cardiac muscle. Circ. Res. 109:262-271. http://dx.doi.org/10 .1161/CIRCRESAHA.111.244244.
56. Hofmann I, Mertens C, Brettel M, Nimmrich V, Schnolzer M, Herrmann H. 2000. Interaction of plakophilins with desmoplakin and intermediate filament proteins: an in vitro analysis. J. Cell Sci. 113:2471- 2483.
57. Siomi MC, Zhang Y, Siomi H, Dreyfuss G. 1996. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Mol. Cell. Biol. 16:3825-3832.
58. Zhong N, Ju W, Nelson D, Dobkin C, Brown WT. 1999. Reduced mRNA for G3BP in fragile X cells: evidence of FMR1 gene regulation. Am. J. Med. Genet. 84:268-271. http://dx.doi.org/10.1002/(SICI)1096-8628 (19990528)84:3<268::AID-AJMG20>3.0.CO;2-#.
59. Siomi MC, Siomi H, Sauer WH, Srinivasan S, Nussbaum RL, Dreyfuss G. 1995. FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J. 14:2401-2408.
60. Sklyarova T, Bonne S, D'Hooge P, Denecker G, Goossens S, De Rycke R, Borgonie G, Bosl M, van Roy F, van Hengel J. 2008. Plakophilin-3- deficient mice develop hair coat abnormalities and are prone to cutaneous inflammation. J. Invest. Dermatol. 128:1375-1385. http://dx.doi.org/10 .1038/sj.jid.5701189.
61. Grossmann KS, Grund C, Huelsken J, Behrend M, Erdmann B, Franke WW, Birchmeier W. 2004. Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. J. Cell Biol. 167:149-160. http://dx.doi.org/10.1083/jcb.200402096.
62. Vasioukhin V, Bowers E, Bauer C, Degenstein L, Fuchs E. 2001. Desmoplakin is essential in epidermal sheet formation. Nat. Cell Biol. 3:1076- 1085. http://dx.doi.org/10.1038/ncb1201-1076.
63. Savagner P, Yamada KM, Thiery JP. 1997. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J. Cell Biol. 137:1403- 1419. http://dx.doi.org/10.1083/jcb.137.6.1403.
64. Aigner K, Descovich L, Mikula M, Sultan A, Dampier B, Bonne S, van Roy F, Mikulits W, Schreiber M, Brabletz T, Sommergruber W, Schweifer N, Wernitznig A, Beug H, Foisner R, Eger A. 2007. The transcription factor ZEB1 (δEF1) represses plakophilin 3 during human cancer progression. FEBS Lett. 581:1617-1624. http://dx.doi.org/10.1016/j.febslet.2007 .03.026.
65. Muller J, Ritt DA, Copeland TD, Morrison DK. 2003. Functional analysis of C-TAK1 substrate binding and identification of PKP2 as a new C-TAK1 substrate. EMBO J. 22:4431-4442. http://dx.doi.org/10.1093 /emboj/cdg426.
66. Pasdar M, Nelson WJ. 1988. Kinetics of desmosome assembly in Madin- Darby canine kidney epithelial cells: temporal and spatial regulation of desmoplakin organization and stabilization upon cell-cell contact. I. Biochemical analysis. J. Cell Biol. 106:677-685.
67. Reynolds AB. 2007. p120-catenin: past and present. Biochim. Biophys. Acta 1773:2-7. http://dx.doi.org/10.1016/j.bbamcr.2006.09.019.
68. van Hengel J, van Roy F. 2007. Diverse functions of p120ctn in tumors. Biochim. Biophys. Acta 1773:78-88. http://dx.doi.org/10.1016/j.bbamcr .2006.08.033.
69. Reynolds AB, Roczniak-Ferguson A. 2004. Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene 23:7947-7956. http://dx .doi.org/10.1038/sj.onc.1208161.
70. Clevers H. 2006. Wnt/beta-catenin signaling in development and disease. Cell 127:469-480. http://dx.doi.org/10.1016/j.cell.2006.10.018.
71. Ying Y, Tao Q. 2009. Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers. Epigenetics 4:307-312. http://dx.doi .org/10.4161/epi.4.5.9371.
72. Chamieh H, Ballut L, Bonneau F, Le Hir H. 2008. NMD factors UPF2 and UPF3 bridge UPF1 to the exon junction complex and stimulate its RNA helicase activity. Nat. Struct. Mol. Biol. 15:85-93. http://dx.doi.org /10.1038/nsmb1330.
73. Mazroui R, Huot ME, Tremblay S, Filion C, Labelle Y, Khandjian EW. Trapping of messenger RNA by Fragile X Mental Retardation protein into cytoplasmic granules induces translation repression. Hum. Mol. Genet. 11:3007-3017. http://dx.doi.org/10.1093/hmg/11.24.3007.
74. Lunde BM, Moore C, Varani G. 2007. RNA-binding proteins: modular design for efficient function. Nat. Rev. Mol. Cell Biol. 8:479-490. http: //dx.doi.org/10.1038/nrm2178.
75. Baltz AG, Munschauer M, Schwanhausser B, Vasile A, Murakawa Y, Schueler M, Youngs N, Penfold-Brown D, Drew K, Milek M, Wyler E, Bonneau R, Selbach M, Dieterich C, Landthaler M. 2012. The mRNAbound proteome and its global occupancy profile on protein-coding transcripts. Mol. Cell 46:674-690. http://dx.doi.org/10.1016/j.molcel.2012.05 .021.
76. Castello A, Fischer B, Eichelbaum K, Horos R, Beckmann BM, Strein C, Davey NE, Humphreys DT, Preiss T, Steinmetz LM, Krijgsveld J, Hentze MW. 2012. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 149:1393-1406. http://dx.doi.org/10 .1016/j.cell.2012.04.031.
77. Schmidt A, Langbein L, Pratzel S, Rode M, Rackwitz HR, Franke WW. Plakophilin 3: a novel cell-type-specific desmosomal plaque protein. Differentiation 64:291-306. http://dx.doi.org/10.1046/j.1432-0436.1999 .6450291.x.
78. Choi HJ, Weis WI. 2005. Structure of the armadillo repeat domain of plakophilin 1. J. Mol. Biol. 346:367-376. http://dx.doi.org/10.1016/j.jmb .2004.11.048.
79. Davidovic L, Durand N, Khalfallah O, Tabet R, Barbry P, Mari B, Sacconi S, Moine H, Bardoni B. 2013. A novel role for the RNA-binding protein FXR1P in myoblasts cell-cycle progression by modulating p21/ Cdkn1a/Cip1/Waf1 mRNA stability. PLoS Genet. 9:e1003367. http://dx .doi.org/10.1371/journal.pgen.1003367.
80. Pasquinelli AE. 2012. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat. Rev. Genet. 13:271- 282. http://dx.doi.org/10.1038/nrg3162.
81. Palanisamy V, Jakymiw A, Van Tubergen EA, D'Silva NJ, Kirkwood KL. Control of cytokine mRNA expression by RNA-binding proteins and microRNAs. J. Dent. Res. 91:651-658. http://dx.doi.org/10.1177 /0022034512437372.
82. Hinman MN, Lou H. 2008. Diverse molecular functions of Hu proteins. Cell. Mol. Life Sci. 65:3168-3181. http://dx.doi.org/10.1007/s00018-008 -8252-6.
83. Atasoy U, Curry SL, Lopez de Silanes I, Shyu AB, Casolaro V, Gorospe M, Stellato C. 2003. Regulation of eotaxin gene expression by TNF-alpha and IL-4 through mRNA stabilization: involvement of the RNA-binding protein HuR. J. Immunol. 171:4369-4378. http://dx.doi.org/10.4049 /jimmunol.171.8.4369.
84. Brennan CM, Steitz JA. 2001. HuR and mRNA stability. Cell. Mol. Life Sci. 58:266-277. http://dx.doi.org/10.1007/PL00000854.
85. Levy NS, Chung S, Furneaux H, Levy AP. 1998. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273:6417-6423. http://dx.doi.org/10.1074/jbc.273.11 .6417.
86. Mazan-Mamczarz K, Galban S, Lopez de Silanes I, Martindale JL, Atasoy U, Keene JD, Gorospe M. 2003. RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc. Natl. Acad. Sci. U. S. A. 100:8354-8359. http://dx.doi.org/10.1073/pnas .1432104100.
87. Wang W, Furneaux H, Cheng H, Caldwell MC, Hutter D, Liu Y, Holbrook N, Gorospe M. 2000. HuR regulates p21 mRNA stabilization by UV light. Mol. Cell. Biol. 20:760-769. http://dx.doi.org/10.1128/MCB .20.3.760-769.2000.
88. Abdelmohsen K, Gorospe M. 2010. Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip. Rev. RNA 1:214-229. http://dx .doi.org/10.1002/wrna.4.
89. Kirkpatrick LL, McIlwain KA, Nelson DL. 1999. Alternative splicing in the murine and human FXR1 genes. Genomics 59:193-202. http://dx.doi .org/10.1006/geno.1999.5868.
90. Dube M, Huot ME, Khandjian EW. 2000. Muscle specific fragile X related protein 1 isoforms are sequestered in the nucleus of undifferentiated myoblast. BMC Genet. 1:4. http://dx.doi.org/10.1186/1471-2156-1-4.